Physician profile
James C Kim
NPI 1750479648
$5,974.55
in general payments reported to CMS, 2019-2025
41 companies · $1,429 in 2025
The $1,429 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $165 · 2021: $535 · 2022: $898 · 2023: $1,126 · 2024: $1,094 · 2025: $1,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,648.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $616.50 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $528.51 | 2019-2025 | Xtandi, Myrbetriq |
| Teleflex LLC | $435.07 | 2022-2025 | Urolift, Barrigel |
| Pfizer INC. | $360.67 | 2019-2025 | |
| Urogen Pharma, INC. | $331.10 | 2021-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $264.55 | 2019-2025 | Provenge |
| Boston Scientific Corporation | $263.09 | 2019-2024 | Rezum Generator |
| Bayer Healthcare Pharmaceuticals INC. | $262.72 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $259.91 | 2023-2025 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $252.00 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Convatec INC. | $216.51 | 2021-2025 | |
| Procept Biorobotics Corporation | $171.91 | 2024-2025 | Aquabeam System |
| Antares Pharma, INC. | $165.79 | 2022-2025 | Xyosted |
| Coloplast Corp | $149.18 | 2019-2025 | Speedicath |
| 180 Medical, INC. | $136.19 | 2022-2024 | Gentlecath, Gentlecath Glide |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bluewind Medical | $133.68 | 2024 | Revi |
| Medtronic, INC. | $133.40 | 2022-2023 | Interstim |
| Laborie Medical Technologies Corp. | $122.89 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $107.13 | 2019-2024 | Xiaflex, Aveed |
| Sanofi-Aventis U.S. LLC | $90.00 | 2021 | |
| Abbvie INC. | $88.86 | 2019-2024 | |
| Travere Therapeutics, INC. | $86.50 | 2019-2020 | |
| Mission Pharmacal Company | $75.75 | 2019-2023 | Uribel |
| Genzyme Corporation | $73.17 | 2021-2022 | |
| Tolmar, INC. | $71.85 | 2025 | Eligard, Jatenzo |
| Myovant Sciences INC. | $68.29 | 2021-2022 | |
| Endo USA, INC. | $63.39 | 2024-2025 | Xiaflex |
| Allergan, INC. | $51.64 | 2019-2021 | |
| Becton, Dickinson and Company | $46.45 | 2023 | Bard Urinary Drainage Bag |
| Myriad Genetic Laboratories, INC. | $43.78 | 2022-2024 | Prolaris |
| Axonics, INC. | $42.86 | 2022 | |
| Rochester Medical Corporation | $42.36 | 2021 | |
| Blue Earth Diagnostics | $37.80 | 2019-2021 | |
| Urovant Sciences INC | $34.90 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $24.42 | 2021 | |
| Abbott Laboratories | $23.39 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.30 | 2025 | |
| Olympus America INC. | $21.29 | 2019 | |
| Foundation Medicine, INC. | $20.42 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $19.02 | 2025 | Bard Urinary Drainage Bag |
| Amgen INC. | $15.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.